| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acute promyelocytic leukaemia in low-income and middle-income countries: a Brazilian experience
|
Pereira-Martins, Diego A
|
|
|
11 |
2 |
p. e98-e99
|
artikel
|
| 2 |
Advancements in haemophilia A and health equity: is it time to redefine severity?
|
Weyand, Angela C
|
|
|
11 |
2 |
p. e90-e92
|
artikel
|
| 3 |
2023 ASH Annual Meeting
|
Cookson, Emma
|
|
|
11 |
2 |
p. e94-e96
|
artikel
|
| 4 |
A treatise on clinical trials
|
Hilal, Talal
|
|
|
11 |
2 |
p. e97
|
artikel
|
| 5 |
Diagnostic evaluation of paediatric autoimmune lymphoproliferative immunodeficiencies (ALPID): a prospective cohort study
|
Hägele, Pauline
|
|
|
11 |
2 |
p. e114-e126
|
artikel
|
| 6 |
Efficacy and safety of extended duration letermovir prophylaxis in recipients of haematopoietic stem-cell transplantation at risk of cytomegalovirus infection: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
|
Russo, Domenico
|
|
|
11 |
2 |
p. e127-e135
|
artikel
|
| 7 |
Elotuzumab, lenalidomide, bortezomib, dexamethasone, and autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GMMG-HD6): results from a randomised, phase 3 trial
|
Mai, Elias K
|
|
|
11 |
2 |
p. e101-e113
|
artikel
|
| 8 |
Elotuzumab: no additional effect in patients with newly diagnosed multiple myeloma
|
Tamura, Hideto
|
|
|
11 |
2 |
p. e86-e87
|
artikel
|
| 9 |
Extended duration of letermovir prophylaxis: how long is long enough?
|
Douglas, Abby P
|
|
|
11 |
2 |
p. e88-e90
|
artikel
|
| 10 |
Improving equity for people living with rare diseases
|
The Lancet Haematology,
|
|
|
11 |
2 |
p. e85
|
artikel
|
| 11 |
Lallindra Gooneratne—maintaining treatment flow amid crisis
|
Cavanaugh, Ray
|
|
|
11 |
2 |
p. e100
|
artikel
|
| 12 |
Polatuzumab vedotin plus rituximab and lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma: a cohort of a multicentre, single-arm, phase 1b/2 study
|
Abrisqueta, Pau
|
|
|
11 |
2 |
p. e136-e146
|
artikel
|
| 13 |
Production and supply of blood products in Brazil
|
Kirby, Tony
|
|
|
11 |
2 |
p. e93-e94
|
artikel
|
| 14 |
Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation
|
Penack, Olaf
|
|
|
11 |
2 |
p. e147-e159
|
artikel
|
| 15 |
Prospective characterisation of non-malignant, paediatric lymphoproliferative disease
|
Torgerson, Troy R
|
|
|
11 |
2 |
p. e87-e88
|
artikel
|
| 16 |
Vacuoles in bone marrow progenitors: VEXAS syndrome and beyond
|
Lacombe, Valentin
|
|
|
11 |
2 |
p. e160-e167
|
artikel
|
| 17 |
When cancer disguises: small-cell lung cancer masquerading as HIV-associated lymphoma in leukaemic phase
|
Kurosawa, Shuhei
|
|
|
11 |
2 |
p. e168
|
artikel
|
Tijdschrift beschrijving